XWELL, Inc. (XWEL) - Q1 2025 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly period ended March 31, 2025. XWELL, Inc. operates as a global wellness organization with three reportable segments: XpresSpa (airport spa services), XpresTest (bio-surveillance and public health support), and Naples Wax Center (upscale hair removal and skincare). The company is classified as a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Revenue | $7.02 million | $8.73 million |
| Gross Profit | $1.32 million | $2.67 million |
| Operating Loss | $(3.16) million | $(2.38) million |
| Net Loss (Attributable to XWELL) | $(4.72) million | $(2.51) million |
| Diluted Loss Per Share | $(1.00) | $(0.60) |
| Cash & Cash Equivalents | $3.65 million | $4.55 million (Dec 31, 2024) |
| Marketable Securities | $7.32 million | $7.25 million (Dec 31, 2024) |
| Total Current Assets | $14.84 million | $15.34 million (Dec 31, 2024) |
| Total Current Liabilities | $8.86 million | $9.22 million (Dec 31, 2024) |
| Working Capital | $5.98 million | $6.11 million (Dec 31, 2024) |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by 20% ($1.70 million) year-over-year, primarily driven by lower CDC XpresTest revenue and XpresSpa revenue, partially offset by new Priority Pass revenue.
- Increased Net Loss: Net loss attributable to XWELL increased significantly to $4.72 million from $2.51 million. This was driven by a $3.44 million loss on the issuance of Series G Preferred Stock and a $142,000 loss on the change in fair value of derivative liabilities. These were partially offset by a $2.59 million gain on the change in fair value of warrant liabilities.
- Segment Performance:
- XpresSpa: Revenue decreased to $4.29 million; Operating income improved to $0.80 million (from a loss of $2.78 million in Q1 2024).
- XpresTest: Revenue decreased to $2.18 million; Operating income was $0.62 million (down from $1.67 million).
- Naples Wax: Revenue decreased to $0.55 million; Operating loss was $0.42 million.
- Capital Structure: In January 2025, the company completed a private placement raising $4.0 million gross proceeds ($3.75 million net) via Series G Convertible Preferred Stock and warrants. This resulted in significant non-cash charges related to the fair value of warrants and derivatives.
Guidance, Outlook, Risks, and Unusual Items
- Going Concern Warning: Management has concluded that substantial doubt exists regarding the company's ability to continue as a going concern for at least one year from the issuance date due to recurring losses and insufficient liquidity to fund future operations without additional financing.
- Nasdaq Compliance: On May 13, 2025, the company received notice from Nasdaq that it failed to meet the minimum bid price requirement of $1.00 per share. The company has a compliance period until November 10, 2025, to regain compliance or risk delisting.
- Subsequent Event (Warrant Reclassification): On May 16, 2025, the company amended its Series A and B Warrants. This amendment resulted in the reclassification of the warrants from liabilities to equity, as they now meet the requirements to be indexed to the company's own stock. Pro forma adjustments reflect the removal of the $3.28 million warrant liability.
- Internal Controls: The company identified material weaknesses in internal controls over financial reporting, specifically regarding lease accounting (ASC 842), revenue processes, and monitoring controls over foreign subsidiaries and IT vendors.
- Legal Proceedings: An arbitration proceeding regarding XpresSpa locations in Atlanta (Hartsfield-Jackson) has commenced, though management does not currently anticipate a material adverse effect.
Investor Verification Checklist
- Liquidity Runway: Verify the company's ability to secure additional equity or debt financing given the explicit "substantial doubt" going concern warning.
- Nasdaq Status: Monitor the stock price to ensure it meets the $1.00 minimum bid price requirement by November 10, 2025, to avoid delisting.
- Warrant Accounting: Confirm the impact of the May 2025 Warrant Amendment on future earnings volatility (elimination of fair value changes) and equity dilution.
- Series G Preferred Stock: Review the redemption terms (quarterly installments starting July 2025) and dividend obligations (8% annual, compounding quarterly) to assess cash flow pressure.
- Internal Control Remediation: Assess the progress of the remediation plan for material weaknesses in revenue and lease accounting to ensure future financial statement reliability.